ArticleJournal of nanobiotechnology2025
Starlike Au nanoparticle unleashing siDDIT3 and photothermal power to combat ferroptosis - driven osteoarthritis.
Article in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Nanomaterials targeting ferroptosis for osteoarthritis treatment: a systematic review of preclinical evidence.Journal of nanobiotechnology · 2026Pooled it
- Supramolecular self-assembled polyphenol nanoparticles alleviate osteoarthritis by inhibiting chondrocyte ferroptosis.Materials today. Bio · 2026Article
- Review
- Nanomaterial-Based Photothermal Therapy for Inflammatory Diseases: Intervention Strategies, Synergistic Effects, and Future Challenges.International journal of nanomedicine · 2026Review
- The estrogen-ferroptosis axis in postmenopausal osteoporosis, osteoarthritis, and intervertebral disc degeneration: shared mechanisms and emerging evidence.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoarthritis (OA), the most common degenerative joint disease globally, has garnered increasing attention, and emerging evidence implicated ferroptosis played an important role in both its onset and progression. In this study, we identify DDIT3, a ferroptosis-related gene, from the GEO public database of OA patient data. We demonstrate that DDIT3 accelerates articular cartilage degeneration by promoting ferroptosis, making it a viable target for therapeutic intervention. Based on this ferroptosis target we selected a siRNA to realize multiple synergistic treatment and diagnostic integration of OA by further designing the starlike Au nanoparticles composite system. These nanoparticles modified by chitosan showing positive charge facilitate superior cellular uptake and transfection of siDDIT3, while the unique thorn-like morphology enhancing photothermal effect of nanoparticles when stimulated by near-infrared (NIR) light, the star-shaped Au NPs generate mild heat through the photothermal effect, modulating the OA microenvironment to promote a more favorable setting for gene therapy. Furthermore, star configuration enables surface-enhanced Raman scattering (SERS), which allows for non-invasive, high-precision tracking of nanoparticle distribution. The synergistic combination of siDDIT3-loaded Au NPs and NIR-induced photothermal treatment not only improves the therapeutic outcomes for OA but it also creates a viable translational medicine paradigm, offering a novel approach to treating degenerative diseases through the integration of nanotechnology and gene therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.